GGrantIndex
← Leaderboards

Melanie B Gillingham

Oregon Health & Science University

$7,900,627
Attributed
$9,099,873
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $948.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,917,349 · 7
FDA$1,182,524 · 1

By mechanism

R01$8,226,811 · 4
K01$420,611 · 1
M01$222,975 · 1
R03$147,770 · 1
F32$81,706 · 1

Top collaborators

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Fatty Acids

Research focus

Fatty AcidsFatty Acid OxidationPreventOxidationProductionPlasmaMitochondriaMetabolicProtein DeficiencyLiverMediatingBloodMuscleChild3-Hydroxyacyl-Coa DehydrogenaseFuturePhenotypeAcylcarnitineOxidoreductaseMolecularBlindnessDiet TherapyFunctional DisorderLipids

Grant awards (28)

Exploring the pathophysiology and treatment of LCHADD retinopathy$385,000
R01 · FY2025 · EY · contact PI
The Natural History of LCHAD Retinopathy$563,773
R01 · FY2024 · HD · contact PI
Exploring the pathophysiology and treatment of LCHADD retinopathy$385,000
R01 · FY2024 · EY · contact PI
The Natural History of LCHAD Retinopathy$541,262
R01 · FY2023 · HD · contact PI
Exploring the pathophysiology and treatment of LCHADD retinopathy$385,000
R01 · FY2023 · EY · contact PI
The Natural History of LCHAD Retinopathy$541,262
R01 · FY2022 · HD · contact PI
Exploring the pathophysiology and treatment of LCHADD retinopathy$373,450
R01 · FY2022 · EY · contact PI
The Natural History of LCHAD Retinopathy$530,436
R01 · FY2021 · HD · contact PI
Exploring the pathophysiology and treatment of LCHADD retinopathy$385,000
R01 · FY2021 · EY · contact PI
The Natural History of LCHAD Retinopathy$555,612
R01 · FY2019 · HD · contact PI
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity$384,975
R01 · FY2018 · DK
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity$666,806
R01 · FY2017 · DK
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity$666,806
R01 · FY2016 · DK
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity$679,905
R01 · FY2015 · DK
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation Disorder$65,196
R01 · FY2014 · FD · contact PI
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation Disorder$375,060
R01 · FY2013 · FD · contact PI
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation Disorder$379,155
R01 · FY2012 · FD · contact PI
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation Disorder$363,113
R01 · FY2011 · FD · contact PI
Diet-Induced Insulin Resistance in a Murine Fatty Acid Oxidation Disorder$76,230
R03 · FY2011 · DK · contact PI
Diet-Induced Insulin Resistance in a Murine Fatty Acid Oxidation Disorder$71,540
R03 · FY2010 · DK · contact PI
Fatty Acid Oxidation Disorders & Body Weight Regulation$107,196
K01 · FY2009 · DK · contact PI
Fatty Acid Oxidation Disorders & Body Weight Regulation$107,482
K01 · FY2008 · DK · contact PI
Fatty Acid Oxidation Disorders & Body Weight Regulation$104,089
K01 · FY2007 · DK · contact PI
Fatty Acid Oxidation Disorders & Body Weight Regulation$101,844
K01 · FY2006 · DK · contact PI
DIETARY THERAPY FOR FATTY ACID OXIDATION DEFECTS$172,865
M01 · FY2005 · RR
Diet Therapy of Long-Chain Fatty Acid Oxidation Defects$32,778
F32 · FY2005 · DK
Dietary therapy for fatty acid oxidation defects$50,110
M01 · FY2004 · RR
Diet Therapy of Long-Chain Fatty Acid Oxidation Defects$48,928
F32 · FY2004 · DK